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Increased evidences have demonstrated that gut microbiota targeted diet intervention
can alleviate obesity and related metabolic disorders. The underlying mechanism
of interactions among diet, microbiota, and host still remains unclear. Enterobacter
cloacae B29, an endotoxin-producing strain dominated in the gut of a morbidly obese
volunteer (weight 174.8 kg, BMI 58.8 kg m−2) was isolated and transplanted to
germfree mice (inoculated 1010 cells of B29 per day for 1 week). Using deep mRNA
sequencing technology, we compared different gene expression profiles in the colon
samples of the germfree mice treated with/without B29 and/or high fat diet (HFD) for
16 weeks and identified 279 differential expressed genes in total, including up-regulated
genes Apoa4 (fold change, 2.77), Ido1 (2.66), Cyp4a10 (7.01), and down-regulated
genes Cyp2e1 (0.11), Cyp26b1 (0.34), Akr1b7 (0.42), Adipoq (0.36), Cyp1a1 (0.11),
Apoa1 (0.44), Npc1l1 (0.37), Tff2 (0.13), Apoc1 (0.30), Ctla2a (0.34), Mttp (0.49),
Lpl (0.48). Fifty-nine GO biological processes and five KEGG pathways, particularly
the peroxisome proliferator-activated receptors signaling pathway, were significantly
enriched in response to HFD+B29, which were mainly relevant to inflammation and the
metabolism of lipid, lipoprotein, and sterols. These functional changes were consistent
with the developed obesity, insulin-resistance, and aggravated inflammatory conditions
of the HFD+B29 mice. This work provides insight into the gene expression changes in
response to HFD+B29, helping to understand the mechanism of the interactions among
HFD, B29 and the germfree mice.
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INTRODUCTION
The public health burden of obesity and metabolic disorders increases rapidly worldwide. The
prevalence of these diseases is considered mainly due to the change of environmental factors, such
as diet and lifestyles. Growing evidences have indicated that the gut microbiota is an important
contributor to the development of these diseases (Turnbaugh et al., 2006; Backhed et al., 2007;
Cani et al., 2008; Shen et al., 2013). Clinical trials and animal models have demonstrated that gut
microbiota targeted diet intervention can alleviate obesity and related metabolic disorders.
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In our previous clinical intervention trial, we found
that a diet consisting of whole grains, traditional Chinese
medicinal foods and prebiotics significantly reduced body
weights and improved clinical parameters of volunteers with
obesity (Fei and Zhao, 2013). Particularly, a volunteer (weight
174.8 kg, body mass index 58.8 kg m−2) had lost 51.4 kg
and recovered from hyperglycemia and hypertension at the
end of 23-week trial. Meanwhile, Enterobacter, a genus of
opportunistic pathogens, decreased from 35% relative abundance
of gut bacteria to non-detectable level. Enterobacter cloacae
B29, an Enterobacter strain from this volunteer, was then
isolated and transplanted to germfree mice. It was found
that B29 combined with high fat diet (HFD) resulted in
obesity and insulin resistance in germfree mice whereas B29
or HFD alone did not, confirming the causative role of
B29 in metabolic deteriorations of the germfree mice (Fei
and Zhao, 2013). As a LPS (lipopolysaccharide)-producing
bacterium, B29 provided endotoxin load to the germfree
mice that the B29+HFD group displayed the highest increase
in systemic inflammation with the greatest increase in the
serum amyloid A protein levels and the greatest decrease
in adiponectin secretion. However, analysis with qRT-PCR
(Reverse transcription-quantitative polymerase chain reaction)
and microarray techniques found that the liver and the
epididymal fat pad had significantly increased genes involved
in inflammation while the ileum had not, suggesting the
inflammation was local. The previous study did not investigate
colon, which is an important immune organ, the main site of
microbial fermentation with the highest bacterial concentrations
and an active site of metabolism (Aura, 2008; Laparra and Sanz,
2010).
Many studies have tried to understand the underlying
mechanism of how diet affects gut microbiota and the
interactions between microbiota and the host through
16S rRNA based platform or metagenomic technology.
The former is usually used to trace the change of the
microbiota structure and the latter is to explore the function
of the microbiome. In addition, some studies also have
used microarray or/and qRT-PCR to investigate the gene
expression of the host. However, both methods were restricted
with the number and the sequencing depth of the genes
detectable. A high throughput cDNA sequencing technology,
mRNA-Seq, which is more powerful in characterizing
transcript sequences and gene expressions, hence becomes
an alternative candidate to provide more comprehensive
information.
In this study, to comprehensively understand the mechanisms
of the influences of B29 and HFD on the host, we collected
the colon samples of these mice and measured the gene
expressions using deep mRNA-Seq technology. We first
compared the colon mRNA expression profiling of the
four groups [Normal Chow Diet (NCD)+Luria-Bertani
(LB), NCD+B29, HFD+LB, HFD+B29] and identified 279
differential expressed genes in total. The GO and KEGG
enrichment analysis were then performed based on these
differential expressed genes (DEGs) and regulations in
inflammation and the metabolism of lipid, lipoprotein
and sterols were observed. Finally, we picked the key
DEGs involved in lipid and lipoprotein metabolism,
inflammation and sterol metabolism under the stress of
HFD+B29 and described how they respond to the provided
stimuli.
MATERIALS AND METHODS
Animal Experiment and Ethical Issues
Male C57BL/6J germfree mice purchased from Shanghai SLAC
laboratory Animal Co., Ltd. (Shanghai, China) were raised in
gnotobiotic isolators with a regular 12-h light cycle and supplied
with sterile food and water. Before the age of 6–10 weeks,
all mice were fed with a NCD and water ad libitum. Then
they were randomly divided into four groups, each received
one of the following treatments for 16 weeks: (1) NCD+LB
group: inoculated 0.1 ml sterile LB medium per day for 1 week
and fed with NCD; (2) NCD+B29 group: inoculated 1010 cells
of B29 per mouse in 0.1 ml sterile LB medium per day for
1 week and fed with NCD; (3) HFD+LB group: inoculated
0.1 ml sterile LB medium per day for 1 week and fed with
HFD; (4) HFD+B29 group: inoculated 1010 cells of B29 per
mouse in 0.1 ml sterile LB medium per day for 1 week and
fed with HFD (Fei and Zhao, 2013). At the end of week
16, all the 24 mice (n = 6/group) were killed by decollation.
The colon tissues were collected for the mRNA sequencing,
and the mass of epididymal fat pad, retroperitoneal fat pad,
subcutaneous inguinal fat pad, and mesenteric adipose tissue
were measured.
The experiment and relevant details were approved
by the Institutional Animal Care and Use Committee
(IACUC) of Shanghai Jiao Tong University, and were
performed in accordance with relevant guidelines
and regulations approved by the IACUC of Shanghai
SLAC laboratory Animal Co., Ltd. All the potential
biologically hazardous materials in this study were properly
handled according to the Chinese biosafety laws and
regulations.
Total RNA Extraction and Purification
The total RNA from the colon tissues was extracted
using TRIzol reagent (Invitrogen Life Technologies,
Gaithersburg, MD, USA) and purified with RNeasy mini
kit (QIAGEN, GmBH, Germany) and RNase-Free DNase
Set (QIAGEN, GmBH, Germany), and the experiment was
performed according to the manufacturer’s protocol. The
integrity and quality of the total RNA were checked by
a NanoDrop 1000 spectrophotometer (Thermo Scientific,
Wilmington, DE, USA) and Agilent Bioanalyzer 2100
(Agilent technologies, Santa Clara, CA, USA), respectively.
The ODA260/A280 of the RNA sample was between 1.9
and 2.1.
Library Preparation and Sequencing
The RNA-seq library preparation was performed following
the protocol recommended by the manufacturer (Illumina,
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San Diego, CA, USA). In brief, after purification, the mRNA
was fragmented into small pieces, and the first-strand cDNA
was prepared using random hexamers. Then the second-
strand cDNA synthesis, end repair, addition of a single
A base, and ligation of the adapters were performed. The
products were purified and enriched by PCR to create the
final cDNA library. The mRNA sequencing was done on
the Illumina HiSeq 2500 with paired end 2 × 100 nt
multiplex. The generated original sequence data can be
downloaded from the NCBI GEO database (accession number:
GSE87027).
Bioinformatics and Statistics
The raw Illumina RNA-Seq reads were firstly processed
to trim the adapter using Flexbar_v2.4_linux64 (Dodt
et al., 2012), and to remove the reads shorter than 30 bp
or with ‘N’ base using Prinseq-lite-0.20.3 (Schmieder
and Edwards, 2011). The quality filtered reads were then
mapped to the reference genome, the Mus_musculus genome1
(Mus_musculus_Ensembl_NCBIM37.tar) by Tophat (version
2.0.10) (Trapnell et al., 2009) with default parameters, which
allowed up to two mismatches.
The mapped sequences of each sample were assembled by
Cuﬄinks (Trapnell et al., 2012b). The transcript abundance was
estimated through incorporation of two normalization steps to
ensure that the expression levels for different genes and the
transcripts can be compared across runs, and was expressed as
the unit of measurement fragments per kilobase of transcript per
million mapped fragments (FPKM).
The obtained assembles were then merged by Cuffmerge
(Trapnell et al., 2012b) with the reference annotation1
(Mus_musculus_Ensembl_NCBIM37.tar).
The differential expression analysis of the merged assembles
was then performed with Cuffdiff (Trapnell et al., 2012b). Genes
and transcripts whose |log2 (FoldChange)| ≥ 1 and adjusted
p-value < 0.05 (FDR adjusted with Benjamini–Hochberg) were
picked as significant ones.
The enrichment analysis was performed with FIDEA2
(D’Andrea et al., 2013), and both up-regulated and down-
regulated genes were considered. A threshold of 0.05 for q-value
(FDR adjusted with Benjamini–Hochberg) was used to select
significant enriched GO and pathway terms.
Gene counts of each sample were estimated by HTSeq-0.6.1p1
with the union mode assigning counts to the gene_id attribute3
(Anders et al., 2015), and the relative proportions of genes in each
sample were calculated.
Canonical analysis and multivariate analysis of variance
(MANOVA) clustering were performed under MATLAB R©
R2010b environment.
The Venn diagram was drawn by Venny 2.14. The






The information of the phenotypes related to the DEG was
obtained from the Mouse Genome Informatics (MGI)5.
RESULTS
B29+HFD Significantly Induced Obesity
and Modulated the Colon mRNA
Expression Profiling in Germfree Mice
Using Illumina Hiseq 2500 platform with paired end 2 × 100 nt
multiplex sequencing, 3262.58 million raw reads in total of the
24 colon samples from the germfree mice were obtained. On
average, 98.86% of the raw reads passed the quality control
filtration (longer than 30 bp and without ‘N’ base), with a median
of 129.79 million high quality reads per sample, ranged from
107.81 million to 180.17 million (Supplementary Table S1). The
averaged overall mapping rate to the reference genome (the
Mus_musculus genome) for the high-quality reads was 95.11%
and the multiple alignments rate was 9.99% (Supplementary
Table S2).
Multivariate analysis of variance on the mRNA gene
expression profiling in germfree mice showed that the four
groups were significantly separated (Figures 1A,B). The HFD
was the major factor contributing to the separation, and B29
was the secondary one. The gene expression compositions of
the two groups fed with HFD (HFD+LB, HFD+B29) were
significantly different from those of the other two groups with
NCD (NCD+LB, NCD+B29; Figure 1B, MANOVA, p < 0.001).
Furthermore, either within the HFD groups or the NCD groups,
the group with B29 was significantly different from the group
with LB, indicating that B29 also contributed to the change of
the mRNAs (Figure 1B, MANOVA, HFD+LB vs. HFD+B29,
p < 0.01; NCD+LB vs. NCD+B29, p < 0.05).
The differentiation among the four groups in phenotypes was
somewhat different. According to Fei and Zhao (2013), at the
end of the trial, the body weight, fat pad masses of epididymis,
retroperitoneal, subcutaneous inguinal, and mesenteric adipose
tissues of the mice were measured and we here used these
five physiological indexes representing the targeted phenotype
of the study. MANOVA showed that the phenotype of the
NCD+B29 group was similar to that of the NCD+LB group,
indicating the weak effect of B29 alone on phenotype under
the NCD condition. Compared with the NCD+LB group (body
weight 31.8 ± 1.2 g), the HFD+LB group had enhanced
but not significantly changed body weight (34.4 ± 4.3 g,
adjusted p-value > 0.05, Supplementary Table S3), which was
consistent with the previous reports that germfree mice were
resistant to HFD induced obesity (Turnbaugh et al., 2006;
Backhed et al., 2007). Though these increased indexes caused the
HFD+LB group being differentiated from the NCD+LB and the
NCD+B29 group, no significant difference was observed among
the three groups (Figure 1C). On the contrary, the HFD+B29
group had significantly higher body weight (45.4 ± 6.6 g,
adjusted p-value < 0.01, Supplementary Table S3) and fat pad
mass, making it be most differentiated and be significantly
5http://www.informatics.jax.org/
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different from the rest three groups (Figure 1C, MANOVA,
p < 0.001).
Overall mRNA Gene Differential
Expression Analysis
To facilitate the functional analysis of the mRNAs, the
differential expressed mRNA genes were picked from the
whole gene matrix with Cuffdiff (Trapnell et al., 2012a)
according to the two standards: |log2 (FoldChange)| ≥ 1
and adjusted p-value < 0.05. Compared with the NCD+LB
control group, the NCD+B29, the HFD+LB, and HFD+B29
group had 135, 124, and 129 DEGs, respectively (Table 1,
detailed DEGs were listed in Supplementary Table S4). Both
the NCD+B29 and the HFD+LB group had much larger
number of the up-regulated DEGs. While in the HFD+B29
group, the up- and down-regulated numbers were similar (65
vs. 64).
Of the 279 non-redundant DEGs, only 23 were shared by the
three groups (Figure 2). The group-specific ones occupied 69.2%
of the total DEGs and almost distributed evenly among the three
groups (the NCD+B29, HFD+LB, and HFD+B29 group had
74, 61, and 58 unique DEGs, respectively). This suggested that
the HFD and B29 can affect the mRNA gene expression of the
host colon either alone or together, but their influences might
differ.
GO and KEGG Pathway Enrichment
Based on the Differential Expressed
Genes
According to the obtained 279 DEGs, the significantly enriched
biological process GO terms were shown in Figure 3. Though
there were 135 DEGs between the NCD+B29 group and the
NCD+LB group, no biological process GO term was significantly
enriched, suggesting that the 135 DEGs caused by B29 were
relatively dispersive in biological process. Compared with the
NCD+LB group, HFD+LB group had 13 enriched GO biological
process terms, in particular four of which were related to lipid
metabolism, and two to steroid metabolism. Significant changes
were observed under the HFD+B29 condition that there were
59 enriched GO biological process terms, and particularly 55 of
them appeared only when HFD and B29 co-existed. Within the
59 GO terms, 38 were of our interest since they were relevant
to the phenotype of the germfree mice, of which 14 were related
to lipid metabolism, 9 to lipoprotein metabolism, 13 to sterols
metabolism and 2 to inflammatory response.
The GO enrichment analysis indicated that the effect of HFD
or B29 alone to the host was relatively dispersive, whereas the
joint effect of the two factors on the lipid, lipoprotein, sterols
metabolism and inflammatory response of the host could be
significantly enhanced. This was consistent with the phenotype
changes of the mice during the animal trial that only the
FIGURE 1 | The mRNA gene expression profiling and the physiological indexes of the four groups (NCD+LB, NCD+B29, HFD+LB, and HFD+B29)
were affected by both high fat diet (HFD) and B29. (A) Canonical analysis of the four groups based on the gene count matrix using eight PCs (accounting for
50.5% variation); (B) Multivariate analysis of variance (MANOVA) clustering based on the gene count matrix of the four groups using eight PCs (accounting for 50.5%
variation); (C) MANOVA clustering based on the five physiological indexes (body weight, the mass of the fad pad of epididymis, retroperitoneum, subcutaneous
inguinal, and mesenteric adipose tissue) of the four groups. ∗∗∗p < 0.001, ∗∗p < 0.01,∗p < 0.05.
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A (NCD+LB) vs. B
(NCD+B29)
135 117 18
A (NCD+LB) vs. C
(HFD+LB)
124 96 28
A (NCD+LB) vs. D
(HFD+B29)
129 65 64
FIGURE 2 | Venn diagram of the differential expressed gene numbers
from three comparisons (NCD+LB group vs. NCD+B29 group,
NCD+LB group vs. HFD+LB group, NCD+LB group vs. HFD+B29
group, respectively).
HFD+B29 group had significantly higher body weights, fat pad
masses, triglyceride, and total cholesterol in serum than those of
the other three groups (Fei, 2013).
The significant enriched KEGG pathways of the 279 DEGs
were also obtained (Table 2). With 135 DEGs between the
NCD+B29 group and the NCD+LB group, only two pathways
were significantly enriched. One was the pathway of fat digestion
and absorption, and the other was vitamin digestion and
absorption. Unlike the result obtained by GO enrichment, the
KEGG analysis indicated that B29 alone could increase fat
digestion and absorption. The HFD+LB had five pathways
enriched, including fat digestion and absorption, pancreatic
secretion, protein digestion and absorption, retinol metabolism,
and steroid hormone biosynthesis. This result was similar to
that of the GO, suggesting that HFD alone could increase fat
metabolism.
Using the DEGs between the HFD+B29 group and
the NCD+LB group, five significantly enriched pathways
were found, including fat digestion and absorption, retinol
metabolism, metabolism of xenobiotics by cytochrome P450,
peroxisome proliferator-activated receptor (PPAR) signaling
pathway, tryptophan metabolism. The latter three pathways
appeared only when HFD and B29 co-existed. PPARs are key
nuclear receptor isoforms in the regulation of lipid and glucose
metabolism, which play an important role in the regulation
of obesity-related insulin sensitivity and inflammation. The
significantly enriched PPAR signaling pathway only occurred to
mice under the HFD+B29 condition, suggesting that the HFD
and B29 should be combined together to cause the effect. Our
previous qRT-PCR result obtained from the liver samples of
the same mice also demonstrated that the PPARγ in HFD+B29
was markedly higher than those in the rest three groups (Fei,
2013). Hence, the enriched PPAR signaling pathway might be
an important contributor to the obese, insulin-resistant, and
inflammatory phenotypes of the corresponding HFD+B29
mice.
Relevant Phenotypes and Functions of
the Key DEGs under the Stress of
HFD+B29
From the 59 enriched GO terms under the stress of HFD+B29,
35 non-redundant DEGs of the HFD+B29 group were finally
picked since many DEGs concurrently localized in different
GO terms. These 35 DEGs were then put into the MGI
(Eppig et al., 2015) the international database resource for
the laboratory mouse, to search for their relevant phenotypes.
As a result, 25 out of 35 DEGs were found to be related
to known phenotypes and most of them had multiple
relationships (Figure 4). These 25 key DEGs were annotated
in Table 3. Of the 25 key DEGs, 6 were up-regulated and
19 were down-regulated. The obtained relevant phenotypes
included homeostasis/metabolism (22 DEGs), growth/size/body
(12 DEGs), immune system (11 DEGs), cardiovascular system
(10 DEGs), liver/biliary system (10 DEGs), mortality/aging (8
DEGs), and endocrine/exocrine glands (8 DEGs). The phenotype
searches also confirmed that the key DEGs were indeed
relevant to the observed inflammation and obesity in HFD+B29
mice.
Fifteen non-redundant DEGs of the HFD+B29 group were
further picked out from the 38 GO terms involved in three
biological process categories: inflammation, metabolism of lipid
and lipoprotein, and metabolism of sterols (Figure 5). Three
of them, Apoa4, Ido1, and Cyp4a10 were up-regulated and 12
DEGs were down-regulated, including Cyp2e1, Cyp26b1, Akr1b7,
Adipoq, Cyp1a1, Apoa1, Npc1l1, Tff2, Apoc1, Ctla2a, Mttp, and
Lpl.
Among them, Apoa4, Apoa1, and Apoc1 were related to the
three biological processes simultaneously and Cyp2e1, Adipoq,
Npc1l1, and Mttp were two function-related. Ido1, Tff2, and
Ctla2a were only enriched in the inflammation related GO terms
and Cyp4a10, Cyp26b1, Akr1b7, Cyp1a1, and Lpl were only
enriched in the lipid and lipoprotein metabolism related GO
terms. Genes involved in sterol metabolism related GO terms
were all multiple function genes.
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FIGURE 3 | The significant biological process GO terms enriched according to the obtained differential expressed genes (DEG) (FDR adjusted
q-value < 0.05). The fold-change of each GO term enriched was represented by the color bar. ∗∗∗p < 0.001, ∗∗p < 0.01,∗p < 0.05.
TABLE 2 | The enriched KEGG pathway according to the obtained 279 differential expressed genes.
PATHWAY_ID PATHWAY_NAME A_B A_C A_D
mmu04975 Fat digestion and absorption Enriched Enriched Enriched
mmu04977 Vitamin digestion and absorption Enriched NS NS
mmu04972 Pancreatic secretion NS Enriched NS
mmu04974 Protein digestion and absorption NS Enriched NS
mmu00830 Retinol metabolism NS Enriched Enriched
mmu00140 Steroid hormone biosynthesis NS Enriched NS
mmu00980 Metabolism of xenobiotics by cytochrome P450 NS NS Enriched
mmu03320 PPAR signaling pathway NS NS Enriched
mmu00380 Tryptophan metabolism NS NS Enriched
A: NCD+LB group; B: NCD+B29 group; C: HFD+LB group; D: HFD+B29 group.
DISCUSSION
In this study, we used deep mRNA sequencing technology
to investigate the different gene expression profiles under
the stress with B29 and/or HFD. We found 279 DEGs in
total were significantly regulated. Many DEGs had diverse
functions, but mainly were related to inflammation, metabolism
of lipid, lipoprotein and sterols. Particularly, three genes,
Apoa4, Apoa1, and Apoc1 were related to the three biological
processes simultaneously. Apoa4 had been reported to function
in integrating feeding behavior, intestinal lipid absorption, and
energy storage, and could improve glucose homeostasis by
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FIGURE 4 | The involved phenotypes of the key DEGs between the HFD+B29 group and the NCD+LB group. The blue square means that relationship(s)
existed according to the international database resource for the laboratory mouse mouse genome informatics (MGI).
enhancing insulin secretion (Wang et al., 2012). Its production
ApoA-4-containing lipoprotein was secreted by the small
intestine in response to fat absorption, and was considered as an
endogenous anti-inflammatory protein that could inhibit DSS-
induced inflammation and colitis (Vowinkel et al., 2004), and
could promote cholesterol eﬄux from cultured fibroblasts and
adipose cells in vitro (Ordovas and Schaefer, 2000). The up-
regulation of Apoa4 in the HFD+B29 might be an irritable
response in order to increase insulin secretion and decrease
cholesterol load and inflammation level. While both Apoa1
and Apoc1 were down-regulated. Apoa1 encoded apolipoprotein
A1 (apoA1), the major protein component of high density
lipoprotein (HDL), which played an important role in LPS
neutralization and clearance (Guo et al., 2013), the reverse
cholesterol transport process (Ordovas and Schaefer, 2000),
and was reversely associated with the plasma level of HDL-
Cholesterol (Gordon et al., 1977; Norum et al., 1982; Badimon
et al., 1992; Srinivasan and Berenson, 1995). The absence of
Apoa1 could result in at least a 70% reduction in plasma
HDL levels (Plump et al., 1997), which was a risk factor of
atherogenic dyslipidemia and obesity. The down expression of
the Apoa1 in HFD+B29 might result in less LPS clearance and
thus promote the level of endotoxin load and inflammation
level and might be responsible for the increase of the plasma
high-density lipoprotein cholesterol in the HFD+B29 mice (Fei,
2013). Another gene, Apoc1 had been reported to increase the
LPS-induced inflammatory state (Westerterp et al., 2007). The
overexpression of human apolipoprotein C1 (Apoc1) in mice
could protect mice from obesity and insulin resistance (Jong et al.,
2001) whereas Apoc1 deficient mice usually had decreased HDL-
cholesterol levels (de Haan et al., 2008). The down-regulation
of Apoc1 in the HFD+B29 mice might be responsible for the
occurred obesity, insulin resistance and higher plasma cholesterol
level.
Four genes, Cyp2e1, Adipoq, Npc1l1, and Mttp were two
biological processes-related genes, and all of them were down-
regulated under the stress of HFD+B29. Cyp2e1 was one
of the major cytochrome P450 forms whose expression was
strongly inhibited by inflammatory cytokines in humans and
rodents (Hakkola et al., 2003), and was critically important
in non-alcoholic steatohepatitis development by promoting
oxidative/nitrosative stress, protein modifications, inflammation,
and insulin resistance (Abdelmegeed et al., 2012). Alcohol-
mediated up-regulation of Cyp2e1 may initiate lipid peroxidation
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TABLE 3 | The q-value, fold change and annotation of the key DEGs.
Gene
Name
MGI_ID Regulated q-value log2(fold
change)
Annotations
Apoa4 88051 Up-regulated 0.014 1.47 Enzyme regulator, lipid binding, transporter, cell differentiation, cellular component
organization, establishment of localization, homeostatic process, immune system
process, lipid metabolic process, response to stimulus, system development
Cyp4a10 88611 Up-regulated 0.005 2.81 Oxidoreductase, lipid metabolic process
Ido1 96416 Up-regulated 0.005 1.41 Oxidoreductase, cell death, cell proliferation, immune system process, response to
stimulus, system development
Slc4a11 2138987 Up-regulated 0.005 1.73 Transporter, establishment of localization, homeostatic process
Spp1 98389 Up-regulated 0.005 2.84 Receptor binding, cell death, cell differentiation, homeostatic process, immune
system process, response to stimulus, system development
Iapp 96382 Up-regulated 0.010 1.76 Receptor binding, cell differentiation, homeostatic process
Apoc1 88053 Down-regulated 0.049 −1.72 Establishment of localization, lipid metabolic process
Akr1b7 101918 Down-regulated 0.005 −1.25 Oxidoreductase, lipid metabolic process
Cyp26b1 2176159 Down-regulated 0.005 −1.56 Lipid binding, oxidoreductase, cell death, cell differentiation, cellular component
organization, homeostatic process, immune system process, lipid metabolic
process, response to stimulus, signaling, system development
Apoa1 88049 Down-regulated 0.005 −1.17 Enzyme regulator, lipid binding, receptor binding, transporter, cell differentiation, cell
proliferation, cellular component organization, establishment of localization,
homeostatic process, immune system process, lipid metabolic process, protein
metabolic process, response to stimulus, signaling, system development
Cyp2e1 88607 Down-regulated 0.005 −3.14 Oxidoreductase, lipid metabolic process, response to stimulus
Cyp1a1 88588 Down-regulated 0.005 −3.22 Oxidoreductase, lipid metabolic process, response to stimulus
Npc1l1 2685089 Down-regulated 0.005 −1.44 Cytoskeletal protein binding, transporter, establishment of localization, homeostatic
process, lipid metabolic process
Adipoq 106675 Down-regulated 0.005 −1.48 Carbohydrate derivative binding, receptor binding, nucleic acid-templated
transcription, cell death
cell differentiation, cell proliferation, cellular component organization, establishment
of localization, homeostatic process, immune system process, lipid metabolic
process, protein metabolic process, response to stimulus, signaling, system
development
Lpl 96820 Down-regulated 0.005 −1.06 Carbohydrate derivative binding, hydrolase, lipid binding, receptor binding, cell
differentiation, cellular component organization, establishment of localization,
homeostatic process, lipid metabolic process
Mttp 106926 Down-regulated 0.032 −1.04 Lipid binding, transporter, cellular component organization, establishment of
localization, homeostatic process, lipid metabolic process, protein metabolic
process
Tff2 1306805 Down-regulated 0.005 −2.93 Receptor binding, cell proliferation, establishment of localization, immune system
process, protein metabolic process, response to stimulus, signaling
Car3 88270 Down-regulated 0.005 −2.02 Hydrolase, response to stimulus
Tgm3 98732 Down-regulated 0.005 −3.21 Transferase, cell differentiation, cellular component organization, protein metabolic
process, system development
Atp12a 1926943 Down-regulated 0.005 −1.16 Carbohydrate derivative binding, hydrolase, transporter, establishment of
localization, homeostatic process, response to stimulus
Anpep 5000466 Down-regulated 0.005 −2.14 Hydrolase, cell differentiation, establishment of localization, homeostatic process,
protein metabolic process, system development
Cartpt 1351330 Down-regulated 0.032 −1.21 Receptor binding, cell differentiation, establishment of localization, homeostatic
process, immune system process, protein metabolic process, response to stimulus,
signaling, system development
Slc6a19 1921588 Down-regulated 0.010 −1.05 Transporter, establishment of localization
Slc15a1 1861376 Down-regulated 0.005 −1.06 Transporter, establishment of localization
Aqp4 107387 Down-regulated 0.005 −1.14 Transporter, cellular component organization, establishment of localization,
homeostatic process, immune system process, response to stimulus
by the production of reactive oxygen species (Ekström and
Ingelman-Sundberg, 1989; Ioannides, 1996; Lieber, 1997;
Leclercq et al., 2000). The down-regulation of Cyp2e1 in
the HFD+B29 mice might be a result of the host high level
of inflammation and be responsible for the observed fat
accumulation. Adipoq encoded an adipose-derived hormone
adiponectin (Scherer et al., 1995), which was suggested to
have anti-inflammatory functions by stimulating a ceramidase
activity, and was also a key modulator of lipid and glucose
metabolism. The decreased adiponectin levels were correlated
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FIGURE 5 | The activated biological processes and their related DEGs under the stress of HFD+B29.
with chronic inflammation associated with obesity, type 2
diabetes, insulin resistance, and atherosclerosis (Berg et al.,
2002; Hotamisligil, 2006; Hotamisligil and Erbay, 2008;
Holland et al., 2011; Ouchi et al., 2011). The decreased serum
adiponectin/body weight of the HFD+B29 in our previous
animal experiment (Fei, 2013) might be related to the down-
regulation of the Adipoq. Npc1l1 was considered as a critical
mediator of cholesterol absorption and functioned as a key
modulator of whole-body cholesterol homeostasis (Davis
et al. 2004, 2005, Jia, 2010). Mttp was critical for lipid and
intestinal cholesterol absorption that its reduction might cause
lower plasma lipid concentrations and intestinal deletions
of Mttp could decrease plasma cholesterol concentrations by
45% (Iqbal et al., 2013). The decrease of Npc1l1 and Mttp
might be a host response to the enhanced levels of the plasma
lipid induced by HFD+B29, and also might be responsible
for the decrease of plasma cholesterol concentrations, which
might be a response to the higher cholesterol level in the
HFD+B29.
Three genes, Ido1, Tff2, and Ctla2a were only related to
inflammation. As an important immune-regulator in the colon,
Ido1 was widely distributed in many tissues such as the gut (distal
ileum and colon), lymph nodes, spleen, thymus, and lungs. Over-
expression of Ido1 had been reported under the exacerbation
of colonic inflammation and could alter the production of
inflammatory cytokine including IFN-g, TNF-a, IL-10, and TGF-
b in colons (Takamatsu et al., 2013). The up-regulated Ido1 in
the colon under the stress of HFD+B29 might be a host response
to the corresponding systemic inflammation. Tff2 was a member
of the trefoil factor family (TFF), playing a role in intestinal
mucosal defense and repair, and in tumorigenesis (Leung et al.,
2002). Human TFF2 could enhance the rate of colonic epithelial
repair, and reduce local inflammation in a rat colitis model
(Tran et al., 1999). The decreased expression of this gene in the
HFD+B29 group might contribute to the enhanced level of the
host inflammation. Ctla2a was an immunosuppressive factor and
a cathepsin L (CathL) inhibitor that acted via retinal pigment
epithelium to induce Treg cells (Sugita et al., 2009), which was
reported to be up-regulated in the high-fat diet treated mice
(Chen et al., 2005). However, it was down-regulated under the
condition of HFD+B29.
Five genes, Cyp4a10, Cyp26b1, Akr1b7, Cyp1a1, and Lpl were
only related to lipid and lipoprotein metabolism. Cyp4a10 was
a target gene of PPAR, which may play a significant role in
fatty acid oxidation, and was usually increased expressed in
obese mice (Enriquez et al., 1999). In wild-type mice, HFD
was reported to be associated with a significant increase in
hepatic PPARα mRNA and plasma free fatty acids, leading to
a PPARα-dependent increase in expression of PPARα marker
genes Cyp4a10 (Kersten et al., 1999). The enhanced Cyp4a10
level in this study, was consistent with the obese phenotype of
the HFD+B29 mice. Cyp26b1 was down-regulated in B29+HFD
mice, and it was also reported to be down-regulated transcripts in
obese-susceptible compared to lean-resistant subjects (Marrades
et al., 2011). Akr1b7 was a major regulator of white adipose
tissue development through the inhibition of adipogenesis and
lipogenesis, and lack of Akr1b7 could increase basal adiposity
and predispose to diet-induced obesity (Tirard et al., 2007; Volat
et al., 2012). The down-regulation of Akr1b7 might contribute to
the obese phenotype of the HFD+B29 mice. The down-regulated
Cyp1a1 in the HFD+B29 mice was consistent with previous
study that observed decreased expression of Cyp1a1 in livers
of morbidly obese women compared with massive weight loss
women (Elam et al., 2009). Lpl was related to the hydrolysis
of triglycerides in plasma lipoproteins and generation of fatty
acids (Olivecrona and Olivecrona, 2009; Wang and Eckel, 2009).
Suppressed expression of Lpl in pancreatic beta cells was observed
in obese mice (Nyrén et al., 2012). According to these reports,
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the down-regulation of these four genes was consistent with the
occurrence of the obese phenotype of the host.
The PPAR signaling pathway was enriched based on the
DEGs only when HFD and B29 co-existed. A recent study
reported that high-fat diet modified the PPARγ pathway leading
to disruption of microbial and physiological ecosystem in murine
small intestine (Tomas et al., 2016). Our previous qRT-PCR
result obtained from the liver samples of the same mice also
demonstrated that the PPARγ in HFD+B29 was markedly higher
than those in the rest three groups (Fei, 2013). These results
suggested that the expression of the PPAR signaling pathway
in different tissues could be simultaneously regulated by high-
fat diet. In addition, the PPAR pathway could not be regulated
when germfree mice were only treated with HFD in our study,
indicating that B29 was important and essential for HFD to
regulate the PPAR pathway.
Our previous results had reported that the expression of
the inflammation related genes TNFα, IL-1β, IL-6, IKK-ε, TLR4
increased significantly in the liver and epididymal fat pad but
not in the ileum of the HFD+B29 gnotobiotic mice, Thus, the
previous study supposed that there were local inflammation
induced in the former two tissues but not in the gut (Fei, 2013).
However, in this study, the significantly increased expression
of inflammation-involved genes in the colon gave opposite
evidences. The changed functions indicated by the mRNAs
in the colon cell were consistent with the enhanced serum
LBP, total cholesterol, triglycerides, and the decreased serum
adiponectin/body weight of the HFD+B29 mice, which suggested
that the inflammation indeed occurred in the gut and that
the influence of HFD and B29 on the inflammation and lipid
metabolic were systemic. The previous study could not observed
inflammation in the ileum might due to two reasons, one is
that different parts of the gut (such as ileum and colon) might
have different immune responses to the stress HFD+B29, and
the other might be due to the limited information obtained with
qRT-PCR, which only have several genes of the ileum be checked.
The lack of detection depth in qRT-PCR used in the ileum
samples further implied the importance and power of mRNA
technology.
Both the HFD and B29 could independently and largely
change the mRNA gene expressions as many DEGs were
identified. However, these DEGs were relatively dispersive that
few relevant enriched GO terms or KEGG pathways were
observed under HFD or B29 alone. This may explain why HFD or
B29 alone could not significantly cause the change in body weight
and fat pad masses in the animal trial. The inconsistence between
results from the mRNA profiles and the phenotype in mice
implied that the difference in gene composition may not enough
to reflect the corresponding difference in function. Investigation
of the mRNAs at functional level is a better way to associate the
change of the mRNAs with that in phenotypes.
The significantly enhanced inflammatory response, the
metabolism of lipid, lipoprotein, and sterols under the HFD+B29
condition suggested the synergistic effect of the HFD and B29,
though it was hard to deduce whether B29 could facilitate
HFD to cause effect or vice versa. However, the information
obtained from the mRNA profiles helped to understand why
only the HFD+B29 mice developed obesity, got insulin-resistant
phenotype, and aggravated inflammatory conditions.
This comparative study provided insight into the gene
expression changes corresponding to the stimuli of HFD+B29,
helping to understand the interactions among the HFD, B29 and
the germfree mice, and the phenotype consequences caused by
HFD+B29.
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